Trinity Biotech | TRIB - Equity Capital And Reserves


Trinity Biotech reported $-54.72M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Bayer EUR 29.7B 799M Sep/2025
Bio-Rad Laboratories USD 7.45B 716.8M Dec/2025
EDAP TMS EUR 27.82M 13.07M Jun/2025
J&J USD 78.47B 0 Sep/2025
Mesa Laboratories USD 186.69M 8.22M Dec/2025
OraSure Technologies USD 361.98M 18.74M Sep/2025
Plus Therapeutics USD -1.35M 3.97M Dec/2023
Roche Holding CHF 33.8B 758M Dec/2025
Siemens EUR 65.48B 3.24B Dec/2025
Surmodics USD 118.9M 753K Sep/2024
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Tosoh JPY 803.3B 7.06B Dec/2025
Trinity Biotech USD -54.72M 5.18M Sep/2025
Veracyte USD 1.26B 36.61M Sep/2025